Exhibit 4.2
ALEXION PHARMACEUTICALS, INC.
STOCK OPTION AGREEMENT
----------------------
AGREEMENT made as of the ____ day of _________ 1998 by and between
Alexion Pharmaceuticals, Inc., a Delaware corporation (the "Company") and
(the "Optionee").
W I T N E S S E T H
-------------------
WHEREAS, pursuant to the Alexion Pharmaceuticals, Inc. 1992 Stock
Option Plan for Outside Directors (the "Plan"), the Company desires to grant
to the Optionee and the Optionee desires to accept an option to purchase
shares of common stock, $.0001 par value, of the Company (the "Common Stock")
upon the terms and conditions set forth in this agreement;
NOW, THEREFORE, the parties hereto agree as follows:
1. GRANT. The Company hereby grants to the Optionee an option to
purchase _________ shares of Common Stock, at a purchase price per share of
$________. This option is intended to be treated as an option which does not
qualify as an incentive stock option ("NSO") within the meaning of Section
422 of the Internal Revenue Code of 1986.
2. RESTRICTIONS ON EXERCISABILITY. Except as specifically provided
otherwise herein, the option will become exercisable in accordance with the
following schedule based upon the number of full years of the Optionee's
continuous employment or service with the Company or a subsidiary following
the Grant Date:
Full Incremental Cumulative
Years of Continuous Percentage of Percentage of
Employment/ Option Option
Service Exercisable Exercisable
------------------- ------------- -------------
Less than 1 0% 0%
1 33 1/3% 33 1/3%
2 33 1/3% 66 2/3%
3 33 1/3% 100%
No share of Common Stock may be purchased hereunder unless the Optionee shall
have remained in the continuous employ or service of the Company or a
subsidiary for one year from the Grant Date. If the Optionee performs
services for the Company or a subsidiary in a capacity other than as a
director or employee, then, for purposes hereof, those services will be
deemed to be continuous until they are terminated, and they will be deemed to
be terminated at the time provided therefor in the consulting or other
agreement governing the performance of such services or, if there is no such
agreement, at the time the Company notifies the Optionee that it no longer
contemplates the utilization of such services. Unless sooner terminated, the
option will expire if and to the extent it is not exercised within ten years
from the Grant Date.
3. EXERCISE. The option may be exercised in whole or in part in
accordance with the above schedule by delivering to the Secretary of the
Company (a) a written notice specifying the number of shares to be purchased,
and (b) payment in full of the exercise price, together with the amount, if
any, deemed necessary by the Company to enable it to satisfy any income tax
withholding obligations with respect to the exercise (unless other
arrangements, acceptable to the Company, are made for the satisfaction of
such withholding obligations). The exercise price shall be payable by bank
or certified check. The Company may (in its sole and absolute discretion)
permit all or part of the exercise price to be paid with previously-owned
shares of Common Stock, or in installments (together with interest) evidenced
by the Optionee's secured promissory note.
4. RIGHTS AS STOCKHOLDER. No shares of Common Stock shall be sold or
delivered hereunder until full payment for such shares has been made
(or, to the extent payable in installments, provided for). The Optionee
shall have no rights as a stockholder with respect to any shares covered by
the option until a stock certificate for such shares is issued to him or her.
Except as otherwise provided herein, no adjustment shall be made for
dividends or distributions of other rights for which the record date is prior
to the date such stock certificate is issued.
5. NONTRANSFERABILITY. The option is not assignable or transferable
except upon the Optionee's death to a beneficiary designated by the Optionee
or, if no designated beneficiary shall survive the Optionee, pursuant to the
Optionee's will and/or the laws of descent and distribution. During an
Optionee's lifetime, the option may be exercised only by the Optionee or the
Optionee's guardian or legal representative.
6. TERMINATION OF SERVICE, DISABILITY OR DEATH. If the Optionee
ceases to be employed by or to perform services for the Company and any
subsidiary for any reason other than death or disability, then, unless sooner
terminated under the terms hereof, the option will terminate on the date
three months after the date of the Optionee's termination of employment or
service. If the Optionee's employment or service is terminated by reason of
the Optionee's death or disability (or if the Optionee's employment or
service is terminated by reason of his or her disability and the Optionee
dies within one year after such termination of employment or service), then,
unless sooner terminated under the terns hereof, the option will terminate on
the date one year after the date of such termination of employment or service
(or one year after the Optionee's later death).
7. SECURITIES RESTRICTIONS. If the shares to be issued upon an
exercise of the option are not registered under the Securities Act of 1933,
then, as a further condition of the Company's obligation to issue such
shares, the Optionee may be required to give a representation in writing that
the Optionee is acquiring the shares for his or her own account as an
investment and not with a view to, or for sale in connection with, the
distribution of such shares, and the certificates representing such shares
shall bear a legend to such effect as the company's counsel shall deem
necessary or desirable. The option shall in no event be exercisable and
shares shall not be issued hereunder if, in the opinion
of counsel to the Company, such exercise and/or issuance would result in a
violation of federal or state securities laws.
8. CAPITAL CHANGES, REORGANIZATIONS, ETC.
(a) In case of any post-Grant Date split-up or consolidation of
shares or any like capital adjustment, or the payment of a stock dividend
which increases or decreases the number of outstanding shares of Common
Stock, appropriate adjustment shall be made to the number of shares and the
exercise price per share which may still be purchased under this agreement.
(b) Upon a post-Grant Date merger (other than a merger of the
Company in which the holders of Common Stock immediately prior to the merger
have the same proportionate ownership of common stock in the surviving
corporation immediately after the merger), consolidation, sale of property or
stock, separation, reorganization (other than a mere reincorporation or the
creation of a holding company) or liquidation of the Company, as a result of
which the stockholders of the Company receive cash, stock or other property
in exchange for or in connection with their shares of Common Stock an
("Exchange Transaction"), the Optionee will be permitted to exercise his or
her outstanding option (whether or not otherwise exercisable) and any
outstanding options not exercised before the consummation of the Exchange
Transaction will thereupon terminate. Notwithstanding the preceding
sentence, if, as part of the Exchange Transaction, the shareholders of the
Company receive capital stock of another corporation ("Exchange Stock"), and
if the Board, in its sole discretion, so directs, then all outstanding
options will be converted into options to purchase shares of Exchange Stock.
The amount and price of the converted options will be determined by adjusting
the amount and price of the options granted hereunder on the same basis as
the determination of the number of shares of Exchange Stock the holders of
Common Stock will receive in the Exchange Transaction.
(c) In the event of any adjustment in the number of shares covered
by any option pursuant to the provisions hereof, any fractional shares
resulting from such adjustment will be disregarded and each such option will
cover only the number of full shares resulting from the adjustment.
(d) All adjustments under this paragraph 8 shall be made by the
Board, and its determination as to what adjustments shall be made, and the
extent thereof, shall be final, binding and conclusive.
9. NO EMPLOYMENT RIGHTS. Nothing in this agreement shall give the
Optionee any right to continue in the employ or service of the Company or a
subsidiary, or interfere in any way with the right of the Company to
terminate the employment or service of the Optionee.
10. PROVISIONS OF PLAN. The provisions of the Plan shall govern if an
to the extent that there are inconsistencies between those provisions and the
provisions hereof. The Optionee acknowledges that he or she has received a
copy of the Plan prior to the execution of this agreement.
11. ADMINISTRATION. The committee appointed by the Board to
administer the Plan will have full power and authority to interpret and apply
the provisions of this agreement, and the decision of said committee as to
any matter arising under this agreement shall be binding and conclusive as
to all persons.
12. TERMINATION OF GRANT. Prior to the Grant Date, the Board of
Directors if, and to the extent necessary, in order to successfully
consummate the Company's private placement, may not grant the option, and to
that extent, the Optionee will have no further rights hereunder.
13. MISCELLANEOUS.
(a) This agreement shall be binding upon and shall inure to the
benefit of the parties hereto and their respective successors and permitted
assigns.
(b) This agreement shall be governed by and construed in
accordance with the laws of the State of Delaware. This agreement
constitutes the entire agreement between the parties with respect to the
Subject matter hereof and may not be modified except by written instrument
executed by the parties.
IN WITNESS WHEREOF, this agreement has been executed as of the date
first above written
Alexion Pharmaceuticals, Inc.
By:
-----------------------------------
--------------------------------------
Optionee
